| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 15.827 | 12.241 | 14.246 | 14.078 | 18.760 | 22.606 | 42.295 | 38.209 | 52.949 | 46.093 |
| Total Income - EUR | 15.829 | 12.242 | 14.767 | 15.875 | 24.664 | 32.129 | 58.714 | 42.882 | 53.314 | 46.094 |
| Total Expenses - EUR | 18.316 | 12.271 | 12.502 | 15.689 | 23.320 | 27.161 | 45.691 | 40.959 | 42.212 | 43.250 |
| Gross Profit/Loss - EUR | -2.488 | -28 | 2.264 | 186 | 1.344 | 4.968 | 13.023 | 1.923 | 11.102 | 2.843 |
| Net Profit/Loss - EUR | -2.962 | -373 | 2.005 | 45 | 1.163 | 4.752 | 12.495 | 1.575 | 10.614 | 2.428 |
| Employees | 1 | 1 | 1 | 2 | 2 | 4 | 3 | 3 | 2 | 2 |
Check the financial reports for the company - Vimamed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 8.903 | 8.812 | 8.663 | 8.504 | 8.340 | 19.229 | 8.000 | 8.025 | 9.390 | 8.701 |
| Current Assets | 11.185 | 8.924 | 15.113 | 9.607 | 22.065 | 14.967 | 30.051 | 34.841 | 45.322 | 44.836 |
| Inventories | 7.973 | 7.892 | 7.870 | 7.790 | 7.712 | 7.577 | 7.479 | 7.432 | 7.464 | 7.592 |
| Receivables | 629 | 657 | 540 | 1.134 | 2.576 | 4.430 | 16.937 | 27.186 | 26.137 | 28.904 |
| Cash | 2.583 | 375 | 6.703 | 682 | 11.777 | 2.960 | 5.635 | 222 | 11.721 | 8.340 |
| Shareholders Funds | 13.612 | 13.100 | 14.884 | 14.656 | 15.535 | 19.992 | 32.044 | 33.718 | 44.229 | 46.411 |
| Social Capital | 47 | 47 | 46 | 45 | 44 | 43 | 42 | 43 | 42 | 42 |
| Debts | 6.476 | 4.636 | 8.893 | 3.455 | 14.870 | 14.204 | 6.007 | 9.147 | 10.483 | 7.126 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7810
|
|||||||||
Comments - Vimamed Srl